For- Robin:
A Company with a Mission

  

News: NCI NExT program: first milestone completed with NCI's experiments which confirm hJAA-F11 human lung tumor localization in mouse xenograft with 89Zr labeled antibody.

SBIR NCI grant: hJAA-F11 Imaging for Lung Cancer Differential Diagnosis,   $300,000 funded 4/1/2019.

More News: below

Need & Opportunity

Market Need, Value Proposition, Market Opportunity, Funding


Find Out More

Our Technology


Our Technology, Competitive Advantage, Plan and Strategy, Product Pipeline, Publications



Learn More

About Robin




My Sister and the Company


Read More